XC
RDY icon

XY Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

XY Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$501K Buy
+34,542
New +$466K 0.48% 27
2025
Q4 		– Sell
-22,064
Closed -$308K – 304
2025
Q3 		$308K Sell
22,064
-60,664
-73% -$873K 0.16% 92
2025
Q2 		$1.24M Buy
82,728
+63,039
+320% +$900K 0.86% 22
2025
Q1 		$260K Sell
19,689
-47,520
-71% -$656K 0.07% 159
2024
Q4 		$1.06M Buy
+67,209
New +$1.01M 0.51% 56

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

XY Capital's RDY Position: Q2 2026 in Review

XY Capital opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 34,542 shares worth $501K. The stake represents 0.48% of the portfolio and ranks #27 among its holdings. This is a return to the name: XY Capital previously reported a position in RDY as recently as Q3 2025.

XY Capital first reported a position in RDY in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.24M in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • XY Capital held 34,542 shares of Dr. Reddy's Laboratories worth $501K as of Q2 2026.
  • Dr. Reddy's Laboratories was a new XY Capital position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.48% of XY Capital's portfolio in Q2 2026, its #27 holding.
  • XY Capital first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 5 quarters since.
  • XY Capital's Dr. Reddy's Laboratories position peaked at $1.24M in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on XY Capital's 13F filing for Q2 2026, filed 11 Aug 2026.